A new National Institutes of Health (NIH) funded consortium will work to identify and validate trial-ready biomarkers for small vessel diseases in the brain that contribute to cognitive impairment and dementia. Seven participating research sites across the country will develop their own imaging and fluid-based biomarkers and scale them up across the consortium, explained neurologist Steven M. Greenberg, MD, PhD, who will lead the project’s coordinating center at Massachusetts General Hospital.

Read More